IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 318 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $29,000 | +52.6% | 352 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $19,000 | +35.7% | 352 | +29.4% | 0.01% | +33.3% |
| Q3 2018 | $14,000 | +27.3% | 272 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $11,000 | -31.2% | 272 | -26.7% | 0.00% | -33.3% |
| Q1 2018 | $16,000 | -44.8% | 371 | -35.0% | 0.01% | -45.5% |
| Q4 2017 | $29,000 | -78.7% | 571 | -78.8% | 0.01% | -79.2% |
| Q3 2017 | $136,000 | +1.5% | 2,690 | +2.1% | 0.05% | -5.4% |
| Q2 2017 | $134,000 | +26.4% | 2,635 | 0.0% | 0.06% | +21.7% |
| Q1 2017 | $106,000 | -20.3% | 2,635 | -5.0% | 0.05% | -24.6% |
| Q4 2016 | $133,000 | +54.7% | 2,775 | +18.5% | 0.06% | +52.5% |
| Q3 2016 | $86,000 | +21.1% | 2,341 | -22.7% | 0.04% | +17.6% |
| Q2 2016 | $71,000 | -41.8% | 3,029 | 0.0% | 0.03% | -42.4% |
| Q1 2016 | $122,000 | -15.3% | 3,029 | +29.9% | 0.06% | -7.8% |
| Q4 2015 | $144,000 | – | 2,332 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |